MicroConstants
MicroConstants is a privately-held, GLP-compliant contract research organization founded in 1998 in San Diego, California, providing bioanalysis, drug metabolism, and pharmacokinetic analysis services to pharmaceutical and biotechnology sponsors.
- Company typePrivate
- Founded1998
- HeadquartersSan Diego, United States
- Headcount101–250
- GTM typeB2B
- OfferingServices
What MicroConstants does
MicroConstants is a privately-held, GLP-compliant Contract Research Organization founded in 1998 and headquartered in San Diego, California. The firm specializes in three tightly-related bioanalytical service areas: bioanalysis, drug metabolism, and pharmacokinetic (PK) analysis — the core laboratory disciplines required to characterize how drug candidates are absorbed, distributed, metabolized, and excreted, and to quantify drug and biomarker concentrations in biological matrices. Its positioning is as a focused, mid-sized specialized CRO (101-250 employees) rather than a diversified life sciences services platform, and its regulatory positioning rests on GLP compliance, a credential required for regulated bioanalytical work supporting FDA and other regulatory submissions.
The company is led by co-founders David F. Beyerlein and Gilbert Lam, with Lam serving as President and Chief Scientific Officer — a structure that keeps scientific leadership embedded in the executive team, consistent with the "scientist-to-scientist" engagement model common to bioanalytical CROs. Its business model is fee-for-service professional services revenue, with project-based engagements typical of the CRO segment (scope, timeline, and pricing driven by assay complexity, sample volume, and regulatory requirements). MicroConstants serves pharmaceutical and biotechnology sponsors requiring bioanalytical support for preclinical and clinical drug development programs. Public pricing is not disclosed, consistent with the customized, quote-based nature of bioanalytical study work.
The input data does not disclose revenue figures, customer names, geographic footprint beyond the San Diego headquarters, specific technology platforms, recent funding activity, or recent strategic transactions for MicroConstants. A substantial portion of the aggregated source material describes BioAgilytix (a separate, larger Durham-based bioanalytical CRO) and has been excluded from this assessment to avoid misattribution. As a result, MicroConstants' strategic positioning, technology stack, and recent momentum can only be described at a high level from the available firmographic data.
MicroConstants firmographics
Firmographics- Name
- MicroConstants
- Legal name
- BioAgilytix Labs
- Website
- https://microconstants.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- MicroConstants is a privately-held, GLP-compliant contract research organization founded in 1998 in San Diego, California, providing bioanalysis, drug metabolism, and pharmacokinetic analysis services to pharmaceutical and biotechnology sponsors.
- Ownership category
- akta.pro rank
MicroConstants industry classification
Industry- Product category
- Contract Research Organization
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Bioanalytical Testing (PK/ADA/NAb) (HLAGADAA)
- akta.pro secondary industries
- Cell-Based & Potency Assays (Bioassays) (HLAGADAH), Laboratory Quality & GLP/GCLP Compliance (HLAGAKAK), Clinical Biomarker Testing Services (central labs, trial enrollment/monitoring assays) (HLAAAMAC), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)
Keywords
Where MicroConstants is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Offices7 records
Markets served
MicroConstants business model
Business model- GTM type
- B2B
- Offering type
- Services
Revenue model
- Bioanalytical Laboratory Services: Fee-for-service laboratory testing model providing pharmacokinetic, immunogenicity, biomarker, and CMC analytical services to pharmaceutical and biotech clients. Revenue is generated through project-based contracts for assay development, validation, and sample analysis services performed in GxP-compliant environments.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Project-based laboratory services |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
MicroConstants product offering
Product offeringCore offering
MicroConstants is a GLP-compliant Contract Research Organization providing bioanalysis, drug metabolism, and pharmacokinetic analysis services. The company supports pharmaceutical and biotechnology research programs with regulatory-compliant testing capabilities.
Product overview
BioAgilytix is a global bioanalytical services company offering a unified platform of laboratory services for the pharmaceutical and biotechnology industries. The portfolio centers on four core service areas: Pharmacokinetics (PK) Services, Immunogenicity Services, Biomarker Testing, and CMC Analytical Services. Supporting these core offerings are capability modules including Method Transfer, Assay Development & Validation, Sample Analysis, Kit Production, and Consulting Services. The company also provides specialized techniques (Ligand Binding Assays, Cell-based Assays, Virology Assays, Molecular Assays, Mass Spectrometry) and operates advanced laboratory instrumentation platforms (MSD, PCR, Luminex, Biacore, LC/MS, Flow Cytometers). Operations are conducted across a global laboratory network spanning San Diego, Durham (headquarters), Boston, Hamburg (Europe headquarters), and Australia (via subsidiary 360biolabs), with partner labs in Beijing.
Differentiator
Problem solved
Functional benefit
Products and services
- Bioanalysis Services
- Drug Metabolism Services
- Pharmacokinetic Analysis Services
Quantifiable outcome
- 800+ assays developed annually
- +1 more outcomes
Companies that use MicroConstants
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles1 record
MicroConstants technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature10 records
MicroConstants partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- 360biolabscore360biolabs is a BioAgilytix Company operating as their Australian subsidiary with laboratory locations in Brisbane and Melbourne. It operates under the BioAgilytix brand as an integrated part of their global laboratory network.
Scale indicators5 records
Recent moves3 records
Expansion highlights3 records
MicroConstants competitors and assessment
Company assessmentDirect peers
- Frontage Laboratories: Frontage is a US-headquartered CRO with a bioanalytical, PK, and CMC analytical services business that directly overlaps BioAgilytix's core offerings for pharma and biotech sponsors, including biologics and small molecules. It is one of the closest direct competitors in bioanalytical testing scale and modality coverage.
- Celerion: Celerion specializes in early-phase clinical pharmacology, PK, and bioanalytical services for pharmaceutical and biotech clients, with a strong focus on first-in-human studies. It competes head-to-head with BioAgilytix for PK/PD and bioanalytical study work, particularly in early development.
Broad incumbents
- Eurofins Scientific: Eurofins is a global testing services group with significant bioanalytical, pharmaceutical, and central laboratory capabilities serving pharma, biotech, and life-sciences clients. It competes with BioAgilytix in bioanalytical and biomarker testing but as part of a much broader testing portfolio.
- Charles River Laboratories: Charles River is a large, diversified CRO offering preclinical, bioanalytical, and safety assessment services to pharma and biotech. Its bioanalytical and safety pharmacology units directly overlap BioAgilytix's PK, immunogenicity, and biomarker services but are bundled within a much wider CRO platform.
- Labcorp (incl. Covance/Fortrea): Labcorp, with Covance and the spun-out Fortrea, is a major clinical and bioanalytical services provider serving global pharma and biotech. It overlaps with BioAgilytix in central lab, bioanalytical, and biomarker services, typically as part of integrated clinical trial packages.
- IQVIA: IQVIA is the largest global CRO and life-sciences services company, with central laboratory, bioanalytical, and clinical trial capabilities. It competes with BioAgilytix in bioanalytical and biomarker testing, typically offering these services bundled into enterprise clinical programs.
- WuXi AppTec: WuXi AppTec is a China-headquartered global CRO/CDMO with bioanalytical, DMPK, and biologics services that overlap BioAgilytix's offerings. It is a major global competitor, particularly attractive to sponsors seeking integrated discovery-to-clinical services at competitive cost.
- SGS Life Sciences: SGS offers a global network of life-sciences testing laboratories including bioanalytical, bioequivalence, and central lab services for pharma and biotech. It competes with BioAgilytix in regulated bioanalytical testing as part of a broad testing, inspection, and certification portfolio.
Emerging players
- Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with bioanalytical, PK, and early-phase clinical capabilities serving pharma and biotech. It is a partial peer where BioAgilytix is a sub-contracted bioanalytical provider or where sponsors weigh standalone bioanalytical against bundled CRO offerings.
- Pharmaron: Pharmaron is a China-rooted, global CRO/CDMO offering DMPK, bioanalytical, and biologics services that overlap BioAgilytix's core menu. It is a meaningful emerging competitor in integrated discovery-through-clinical bioanalysis, especially for sponsors seeking Asia-Pacific capacity.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
MicroConstants social profiles
Digital presenceMicroConstants financial estimates
Financial estimateRevenue estimate
Valuation estimate
MicroConstants leadership team
Management profileNumber of profiles
Profiles2 records
MicroConstants subsidiaries and ownership
Company hierarchySubsidiaries1 record
MicroConstants funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
MicroConstants M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about MicroConstants
What does MicroConstants do?
MicroConstants is a GLP-compliant Contract Research Organization providing bioanalysis, drug metabolism, and pharmacokinetic analysis services. The company supports pharmaceutical and biotechnology research programs with regulatory-compliant testing capabilities.
Is MicroConstants a public or private company?
MicroConstants is a private company. It is classified as unknown and is currently operating.
When was MicroConstants founded?
MicroConstants was founded in 1998. It employs 101 to 250 people.
Where is MicroConstants based?
MicroConstants is headquartered in San Diego, United States, in the North America region.
How does MicroConstants make money?
One revenue line is on record: bioanalytical Laboratory Services.
Who are MicroConstants's main competitors?
Direct peers on record are Frontage Laboratories and Celerion. Broad incumbents are Eurofins Scientific, Charles River Laboratories, Labcorp (incl. Covance/Fortrea), IQVIA, WuXi AppTec and SGS Life Sciences. Emerging players are Worldwide Clinical Trials and Pharmaron.
Does MicroConstants have an API?
No public API is recorded for MicroConstants.
What industry is MicroConstants in?
MicroConstants's product category is Contract Research Organization. Its primary akta.pro industry code is HLAGADAA, Bioanalytical Testing (PK/ADA/NAb), with a secondary code of HLAGADAH, Cell-Based & Potency Assays (Bioassays). Its NAICS code is 5417 and its SIC code is 8731.